St. Louis, MO, United States of America

David N Dietzler

This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David N Dietzler. Retrieved from https://idiyas.com/inventor/david-n-dietzler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David N Dietzler: Innovator in Biochemical Assays

Introduction

David N Dietzler is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biochemical assays, particularly in the determination of specific isoenzymes in biological fluids. His work has implications for medical diagnostics and research.

Latest Patents

David N Dietzler holds a patent for a method of determining the CK-MB isoenzyme in a biological fluid. This innovative method involves subjecting a sample of the fluid to an assay system that includes incubating with a monoclonal antibody specific to the CK-MB isoenzyme, while not reacting with CK-MM or CK-BB. This patent represents a significant advancement in the accuracy of biochemical assays.

Career Highlights

Dietzler is affiliated with Washington University, where he has contributed to various research initiatives. His expertise in biochemical assays has positioned him as a valuable asset in the academic and research community.

Collaborations

David has collaborated with esteemed colleagues such as Jack H Ladenson and Hermant C Vaidya, further enhancing the impact of his work in the field.

Conclusion

David N Dietzler's contributions to the field of biochemical assays exemplify the importance of innovation in medical diagnostics. His patented method for determining CK-MB isoenzyme showcases his commitment to advancing scientific knowledge and improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…